Cargando…

Morpho-Molecular Assessment Indicates New Prognostic Aspects and Personalized Therapeutic Options in Sinonasal Melanoma

Sinonasal melanoma is a rare subtype of melanoma and little is known about its molecular fingerprint. Systemic treatment options are limited, as targetable BRAF mutations are rare compared to cutaneous melanoma. Currently, metastatic sinonasal melanoma is being treated according to the guidelines of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Freiberger, Sandra N., Morand, Grégoire B., Turko, Patrick, Wager, Ulrich, Dummer, Reinhard, Hüllner, Martin, Holzmann, David, Rupp, Niels J., Levesque, Mitchell P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6770844/ https://www.ncbi.nlm.nih.gov/pubmed/31500314 http://dx.doi.org/10.3390/cancers11091329

Ejemplares similares

Who’s Driving? Switch of Drivers in Immunotherapy-Treated Progressing Sinonasal Melanoma
por: Freiberger, Sandra N., et al.
Publicado: (2021)

Combinational expression of tumor testis antigens NY-ESO-1, MAGE-A3, and MAGE-A4 predicts response to immunotherapy in mucosal melanoma patients
por: Freiberger, Sandra N., et al.
Publicado: (2022)

Clock-like Mutation Signature May Be Prognostic for Worse Survival Than Signatures of UV Damage in Cutaneous Melanoma
por: Fröhlich, Fabienne, et al.
Publicado: (2023)

The Prognostic Value of a Single, Randomly Timed Circulating Tumor DNA Measurement in Patients with Metastatic Melanoma
por: Boerlin, Aurelio, et al.
Publicado: (2022)

Sinonasal mucosal melanoma treatment response assessment to immune checkpoint inhibitors using hybrid positron emission tomography imaging
por: Maurer, Alexander, et al.
Publicado: (2023)

Reappraisal of Grading in Intestinal-Type Sinonasal Adenocarcinoma: Tumor Budding as an Independent Prognostic Parameter
por: Meerwein, Christian M., et al.
Publicado: (2022)

Correction: Stalder, et al.; Value of SUV(max) for the Prediction of Bone Invasion in Oral Squamous Cell Carcinoma. Biology 2020, 9, 23
por: Stalder, Stephanie A., et al.
Publicado: (2020)

Value of SUV(max) for the Prediction of Bone Invasion in Oral Squamous Cell Carcinoma
por: Stalder, Stephanie A., et al.
Publicado: (2020)

Predictive Value of Pretherapeutic Maximum Standardized Uptake Value (Suv(max)) In Laryngeal and Hypopharyngeal Cancer
por: Werner, Jonas, et al.
Publicado: (2019)

Impact of Covid-19 on the management of patients with metastatic melanoma
por: Welti, Michèle, et al.
Publicado: (2022)

Loss of YY1, a Regulator of Metabolism in Melanoma, Drives Melanoma Cell Invasiveness and Metastasis Formation
por: Guendisch, Ulf, et al.
Publicado: (2022)

Addendum: Impact of Covid-19 on the management of patients with metastatic melanoma
por: Welti, Michèle, et al.
Publicado: (2023)

Clinicopathological and Genomic Profiles of Atypical Fibroxanthoma and Pleomorphic Dermal Sarcoma Identify Overlapping Signatures with a High Mutational Burden
por: Ak, Melike, et al.
Publicado: (2021)

Co-existence of BRAF and NRAS driver mutations in the same melanoma cells results in heterogeneity of targeted therapy resistance
por: Raaijmakers, Marieke I. G., et al.
Publicado: (2016)

Evolution in Sinonasal Mucosal Melanoma Management
por: Richa, Tony, et al.
Publicado: (2022)

Sinonasal Cancer: Improving Classification, Stratification and Therapeutic Options
por: Hermsen, Mario A., et al.
Publicado: (2023)

Melanoma patients with additional primary cancers: a single-center retrospective analysis
por: Dimitriou, Florentia, et al.
Publicado: (2019)

PTEN Methylation Dependent Sinonasal Mucosal Melanoma
por: Lee, Sang Hee, et al.
Publicado: (2016)

Contemporary Multidisciplinary Management of Sinonasal Mucosal Melanoma
por: Na’ara, Shorook, et al.
Publicado: (2020)

Predictive value of suvmax changes between two sequential post-therapeutic FDG-pet in head and neck squamous cell carcinomas
por: Stadler, Thomas M., et al.
Publicado: (2020)

Expanding the clinicopathological spectrum of TGFBR3‐PLAG1 rearranged salivary gland neoplasms with myoepithelial differentiation including evidence of high‐grade transformation
por: Rupp, Niels J., et al.
Publicado: (2021)

Histopathological Analysis of Nodal Disease After Chemoradiation Reveals Viable Tumor Cells as the most Important Prognostic Factor in Head and Neck Squamous Cell Carcinoma, DOI 10.1007/s12105-023-01557-7
por: Morand, Grégoire B., et al.
Publicado: (2023)

Establishing standardized immune phenotyping of metastatic melanoma by digital pathology
por: Sobottka, Bettina, et al.
Publicado: (2021)

Editorial: Abiotic stress alleviation in plants: morpho-physiological and molecular aspects
por: Magdy, Mahmoud, et al.
Publicado: (2023)

Correction: Establishing standardized immune phenotyping of metastatic melanoma by digital pathology
por: Sobottka, Bettina, et al.
Publicado: (2021)

Whole‐body hybrid positron emission tomography imaging yields clinically relevant information in the staging and restaging of sinonasal tumors
por: Maurer, Alexander, et al.
Publicado: (2021)

Sinonasal Melanoma: A Case Report and Literature Review
por: Alves, I. S. S., et al.
Publicado: (2017)

Sinonasal Malignant Melanoma Variant: A Case Report
por: Alqurashi, Alshema, et al.
Publicado: (2022)

Advanced Sinonasal Malignant Melanoma; A Case Report
por: Khorasani Esmaili, Parisa, et al.
Publicado: (2023)

Differentiated Papillary NUT Carcinoma: An Unexpected, Deceptively Bland Presentation of a Sinonasal Carcinoma
por: Wartenberg, Martin, et al.
Publicado: (2023)

Evaluation of the Interplay between the ADAR Editome and Immunotherapy in Melanoma
por: Tusup, Marina, et al.
Publicado: (2021)

The low affinity neurotrophin receptor CD271 regulates phenotype switching in melanoma
por: Restivo, Gaetana, et al.
Publicado: (2017)

Specific Activation of the CD271 Intracellular Domain in Combination with Chemotherapy or Targeted Therapy Inhibits Melanoma Progression
por: Saltari, Annalisa, et al.
Publicado: (2021)

Toxicity of combined targeted therapy and concurrent radiotherapy in metastatic melanoma patients: a single-center retrospective analysis
por: Ziegler, Johanna S., et al.
Publicado: (2020)

The role of cyclin D1 and Ki‐67 in the development and prognostication of thin melanoma
por: Kaufmann, Corina, et al.
Publicado: (2020)

Publisher Correction: The low affinity neurotrophin receptor CD271 regulates phenotype switching in melanoma
por: Restivo, Gaetana, et al.
Publicado: (2018)

Targeted treatment of advanced NRAS-mutated melanoma
por: Koelblinger, Peter, et al.
Publicado: (2017)

Proteomics-based insights into mitogen-activated protein kinase inhibitor resistance of cerebral melanoma metastases
por: Zila, Nina, et al.
Publicado: (2018)

MorphoCluster: Efficient Annotation of Plankton Images by Clustering
por: Schröder, Simon-Martin, et al.
Publicado: (2020)

The A to I editing landscape in melanoma and its relation to clinical outcome
por: Amweg, Austeja, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_obeugravm201rnnl1r95b5v388